These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 30954437)

  • 41. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.
    Mackenzie IR; Munoz DG
    Neurology; 1998 Apr; 50(4):986-90. PubMed ID: 9566383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Gene therapy and Alzheimer's disease].
    Li J; Li W; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 40(4):428-32. PubMed ID: 25931222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches.
    Singh RK
    Curr Neuropharmacol; 2020; 18(9):868-882. PubMed ID: 31989900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence.
    Szekely CA; Zandi PP
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):132-9. PubMed ID: 20205647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular interaction study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 kinase and JNK kinase.
    Batool S; Nawaz MS; Greig NH; Rehan M; Kamal MA
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(2):129-35. PubMed ID: 23360257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease.
    Agdeppa ED; Kepe V; Liu J; Small GW; Huang SC; Petric A; Satyamurthy N; Barrio JR
    Mol Imaging Biol; 2003; 5(6):404-17. PubMed ID: 14667495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of inflammation in Alzheimer's disease.
    Tuppo EE; Arias HR
    Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
    Imbimbo BP
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
    Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
    Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease: dissecting the epidemiological evidence.
    Launer L
    Drugs; 2003; 63(8):731-9. PubMed ID: 12662122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
    Lee M; McGeer E; McGeer PL
    Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metal and inflammatory targets for Alzheimer's disease.
    Rogers JT; Lahiri DK
    Curr Drug Targets; 2004 Aug; 5(6):535-51. PubMed ID: 15270200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease.
    Uddin MS; Kabir MT; Mamun AA; Barreto GE; Rashid M; Perveen A; Ashraf GM
    Int Immunopharmacol; 2020 Jul; 84():106479. PubMed ID: 32353686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
    McGeer PL; Rogers J; McGeer EG
    J Alzheimers Dis; 2006; 9(3 Suppl):271-6. PubMed ID: 16914866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly.
    Sardi F; Fassina L; Venturini L; Inguscio M; Guerriero F; Rolfo E; Ricevuti G
    Autoimmun Rev; 2011 Dec; 11(2):149-53. PubMed ID: 21996556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease.
    Hoozemans JJ; Veerhuis R; Rozemuller AJ; Eikelenboom P
    Curr Drug Targets; 2003 Aug; 4(6):461-8. PubMed ID: 12866660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile.
    Agdeppa ED; Kepe V; Petri A; Satyamurthy N; Liu J; Huang SC; Small GW; Cole GM; Barrio JR
    Neuroscience; 2003; 117(3):723-30. PubMed ID: 12617976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypertension and inflammation in Alzheimer's disease: close partners in disease development and progression!
    Nelson L; Gard P; Tabet N
    J Alzheimers Dis; 2014; 41(2):331-43. PubMed ID: 24614908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
    Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
    J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
    Dong Y; Li X; Cheng J; Hou L
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.